| A role for uncoupling protein‐2 as a regulator of mitochondrial hydrogen peroxide generation A Nègre‐Salvayre, C Hirtz, G Carrera, R Cazenave, M Troly, R Salvayre, ... The FASEB Journal 11 (10), 809-815, 1997 | 923 | 1997 |
| The B1-agonist [des-Arg10]-kallidin activates transcription factor NF-kappaB and induces homologous upregulation of the bradykinin B1-receptor in cultured human lung fibroblasts. JP Schanstra, E Bataillé, MEM Castano, Y Barascud, C Hirtz, ... The Journal of clinical investigation 101 (10), 2080-2091, 1998 | 221 | 1998 |
| Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification NR Barthélemy, RJ Bateman, C Hirtz, P Marin, F Becher, C Sato, ... Alzheimer's research & therapy 12, 1-11, 2020 | 211 | 2020 |
| Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study J Fortea, M Carmona-Iragui, B Benejam, S Fernández, L Videla, ... The Lancet Neurology 17 (10), 860-869, 2018 | 189 | 2018 |
| Current and future use of “dried blood spot” analyses in clinical chemistry S Lehmann, C Delaby, J Vialaret, J Ducos, C Hirtz Clinical Chemistry and Laboratory Medicine (CCLM) 51 (10), 1897-1909, 2013 | 181 | 2013 |
| Exocytosis and protein secretion in Trypanosoma A Geiger, C Hirtz, T Bécue, E Bellard, D Centeno, D Gargani, M Rossignol, ... BMC microbiology 10, 1-17, 2010 | 179 | 2010 |
| Characterization of pre‐analytical sample handling effects on a panel of Alzheimer's disease–related blood‐based biomarkers: results from the Standardization of Alzheimer's … IMW Verberk, EO Misdorp, J Koelewijn, AJ Ball, K Blennow, JL Dage, ... Alzheimer's & Dementia 18 (8), 1484-1497, 2022 | 143 | 2022 |
| Differential mass spectrometry profiles of tau protein in the cerebrospinal fluid of patients with Alzheimer’s disease, progressive supranuclear palsy, and dementia with lewy … NR Barthélemy, A Gabelle, C Hirtz, F Fenaille, N Sergeant, ... Journal of Alzheimer's Disease 51 (4), 1033-1043, 2016 | 141 | 2016 |
| FTO-mediated cytoplasmic m6Am demethylation adjusts stem-like properties in colorectal cancer cell S Relier, J Ripoll, H Guillorit, A Amalric, C Achour, F Boissière, J Vialaret, ... Nature communications 12 (1), 1716, 2021 | 129 | 2021 |
| Tau protein quantification in human cerebrospinal fluid by targeted mass spectrometry at high sequence coverage provides insights into its primary structure heterogeneity NR Barthélemy, F Fenaille, C Hirtz, N Sergeant, S Schraen-Maschke, ... Journal of proteome research 15 (2), 667-676, 2016 | 120 | 2016 |
| MS characterization of multiple forms of alpha‐amylase in human saliva C Hirtz, F Chevalier, D Centeno, V Rofidal, JC Egea, M Rossignol, ... Proteomics 5 (17), 4597-4607, 2005 | 106 | 2005 |
| Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity X Ayrignac, E Le Bars, C Duflos, C Hirtz, A Maleska Maceski, ... Scientific reports 10 (1), 10923, 2020 | 102 | 2020 |
| Cerebrospinal fluid levels of orexin-A and histamine, and sleep profile within the Alzheimer process A Gabelle, I Jaussent, C Hirtz, J Vialaret, S Navucet, C Grasselli, P Robert, ... Neurobiology of aging 53, 59-66, 2017 | 97 | 2017 |
| Impact of harmonization of collection tubes on Alzheimer's disease diagnosis S Lehmann, S Schraen, I Quadrio, C Paquet, S Bombois, C Delaby, ... Alzheimer's & Dementia 10, S390-S394. e2, 2014 | 86 | 2014 |
| Serum neurofilament light chain at time of diagnosis is an independent prognostic factor of survival in amyotrophic lateral sclerosis E Thouvenot, C Demattei, S Lehmann, A Maceski‐Maleska, C Hirtz, ... European Journal of Neurology 27 (2), 251-257, 2020 | 79 | 2020 |
| Matrix‐assisted laser desorption/ionization imaging mass spectrometry of oxaliplatin derivatives in heated intraoperative chemotherapy (HIPEC)‐like treated rat kidney A Bouslimani, N Bec, M Glueckmann, C Hirtz, C Larroque Rapid Communications in Mass Spectrometry: An International Journal Devoted …, 2010 | 78 | 2010 |
| Differential diagnostic performance of a panel of plasma biomarkers for different types of dementia EH Thijssen, IMW Verberk, J Kindermans, A Abramian, J Vanbrabant, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 14 (1 …, 2022 | 74 | 2022 |
| RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma E Viziteu, B Klein, J Basbous, YL Lin, C Hirtz, C Gourzones, L Tiers, ... Leukemia 31 (10), 2104-2113, 2017 | 74 | 2017 |
| Alzheimer’s disease: advances in drug development M Piton, C Hirtz, C Desmetz, J Milhau, AD Lajoix, K Bennys, S Lehmann, ... Journal of Alzheimer's Disease 65 (1), 3-13, 2018 | 71 | 2018 |
| Proteins and proteolysis in pre-term and term human milk and possible implications for infant formulae E Armaforte, E Curran, T Huppertz, CA Ryan, MF Caboni, PM O’Connor, ... International Dairy Journal 20 (10), 715-723, 2010 | 71 | 2010 |
Sylvain LehmannProfessor of Biochemistry, Montpellier UniversityAdresse e-mail validée de umontpellier.fr
